Literature DB >> 12934185

Systemic cytokine responses in patients with influenza-associated encephalopathy.

Jun-ichi Kawada1, Hiroshi Kimura, Yoshinori Ito, Shinya Hara, Masahiro Iriyama, Tetsushi Yoshikawa, Tsuneo Morishima.   

Abstract

Influenza-associated encephalopathy, a severe neurologic complication of influenza, is being reported more frequently in Japan. We investigated the transcription of cytokine genes in peripheral blood leukocytes and compared patients with influenza and with encephalopathy or febrile convulsions and patients with influenza but without neurologic complications. A quantitative polymerase chain reaction (PCR) revealed that transcription of the interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha genes was up-regulated to a greater extent in patients with encephalopathy than in those without neurologic complications. Plasma IL-6 levels also were higher in patients with encephalopathy, although the difference was marginal. Viral RNA in throat swabs was quantified using a real-time quantitative PCR. The virus load was similar among patients with encephalopathy or febrile convulsions or without neurologic complications. Furthermore, virus load was not correlated with either the transcription of cytokine genes or plasma cytokine concentrations. These results suggest that influenza-associated encephalopathy might be a consequence of systemic immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934185     DOI: 10.1086/377101

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Influenza virus associated encephalopathy.

Authors:  R Surtees; C DeSousa
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

Review 2.  Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Authors:  Kathryn A Frankola; Nigel H Greig; Weiming Luo; David Tweedie
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

Review 3.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

Review 4.  Pathology of human influenza revisited.

Authors:  Thijs Kuiken; Jeffery K Taubenberger
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

5.  Tumor necrosis factor alpha antibody prevents brain damage of rats with acute necrotizing pancreatitis.

Authors:  Yan-Ling Yang; Ji-Peng Li; Kai-Zong Li; Ke-Feng Dou
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

6.  Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus.

Authors:  A-E Tolnay; C R Baskin; T M Tumpey; P J Sabourin; C L Sabourin; J P Long; J A Pyles; R A Albrecht; A García-Sastre; M G Katze; H Bielefeldt-Ohmann
Journal:  Arch Virol       Date:  2010-04-07       Impact factor: 2.574

7.  Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection.

Authors:  T Takano; H Tajiri; Y Kashiwagi; S Kimura; H Kawashima
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-06       Impact factor: 3.267

8.  Immune dysregulation in severe influenza.

Authors:  Meredith L Heltzer; Susan E Coffin; Kelly Maurer; Asen Bagashev; Zhe Zhang; Jordan S Orange; Kathleen E Sullivan
Journal:  J Leukoc Biol       Date:  2009-06       Impact factor: 4.962

Review 9.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

10.  Acute encephalopathy associated with influenza A infection in adults.

Authors:  Nelson Lee; Chun Kwok Wong; Paul K S Chan; Niklas Lindegardh; Nicholas J White; Frederick G Hayden; Edward H C Wong; Ka Shing Wong; Clive S Cockram; Joseph J Y Sung; David S C Hui
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.